Anhydroglucitol in Children With Type 1 Diabetes
Anhydroglucitol as a Measure of the Functional Beta-cell Mass in Children With Type 1 Diabetes - Pilot Study
Sponsor: University Hospital, Geneva
This observational or N/A phase trial investigates Diabetes Mellitus, Type 1 and is currently actively recruiting participants. University Hospital, Geneva leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
May 2025 — Present [monthly]
Recruiting
-
Sep 2024 — May 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Jun 2023 — Jul 2024 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Nov 2022 — Jun 2023 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Geneva
- University of Geneva, Switzerland
For direct contact, visit the study record on ClinicalTrials.gov .